| 1 | [SID103590572] | Active | Kd | 0.00086 | Displacement of [3H]CP-55940 from CB1 receptor in mouse brain at 100 nM [AID409807, Type: Literature] | Cannabinoid receptor 1 [gi:1345697] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | Kd | 0.00086 [uM] | | BioAssay | Displacement of [3H]CP-55940 from CB1 receptor in mouse brain at 100 nM | | AID | 409807 | | BioAssay type | Literature | | Target | Cannabinoid receptor 1 [gi:1345697] | | PubMed | 18752948 | | Data Table |  |
|
| 2 | [SID103590572] | Active | IC50 | 0.003 | Displacement of [3H]CP-55940 from mouse CB1 receptor expressed in HEK293 cells [AID409805, Type: Literature] | Cannabinoid receptor 1 [gi:1345697] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.003 [uM] | | BioAssay | Displacement of [3H]CP-55940 from mouse CB1 receptor expressed in HEK293 cells | | AID | 409805 | | BioAssay type | Literature | | Target | Cannabinoid receptor 1 [gi:1345697] | | PubMed | 18752948 | | Data Table |  |
|
| 3 | [SID103590572] | Active | IC50 | 0.01 | Displacement of 2-arachidonylglycerol from MAGL in Swiss Webster mouse brain after 5 mins [AID503381, Type: Literature] | Monoglyceride lipase [gi:47117040] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Displacement of 2-arachidonylglycerol from MAGL in Swiss Webster mouse brain after 5 mins | | AID | 503381 | | BioAssay type | Literature | | Target | Monoglyceride lipase [gi:47117040] | | PubMed | 18438404 | | Data Table |  |
|
| 4 | [SID103590572] | Active | IC50 | 0.01 | Displacement of 2-arachidonylglycerol from MAGL in Swiss Webster mouse brain after 5 mins [AID503381, Type: Literature] | Monoglyceride lipase [gi:47117040] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Displacement of 2-arachidonylglycerol from MAGL in Swiss Webster mouse brain after 5 mins | | AID | 503381 | | BioAssay type | Literature | | Target | Monoglyceride lipase [gi:47117040] | | PubMed | 18438404 | | Data Table |  |
|
| 5 | [SID103590572] | Active | IC50 | 0.01 | Inhibition of MAGL-mediated 2-arachidonoylglycerol hydrolysis in mouse brain [AID409757, Type: Literature] | Monoglyceride lipase [gi:47117040] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Inhibition of MAGL-mediated 2-arachidonoylglycerol hydrolysis in mouse brain | | AID | 409757 | | BioAssay type | Literature | | Target | Monoglyceride lipase [gi:47117040] | | PubMed | 18752948 | | Data Table |  |
|
| 6 | [SID103590572] | Active | IC50 | 0.01 | Inhibition of MAGL-mediated 2-arachidonoylglycerol hydrolysis in mouse brain [AID409757, Type: Literature] | Monoglyceride lipase [gi:47117040] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Inhibition of MAGL-mediated 2-arachidonoylglycerol hydrolysis in mouse brain | | AID | 409757 | | BioAssay type | Literature | | Target | Monoglyceride lipase [gi:47117040] | | PubMed | 18752948 | | Data Table |  |
|
| 7 | [SID103590572] | Active | IC50 | 0.01 | Displacement of [3H]CP-55940 from CB1 receptor in mouse brain [AID409760, Type: Literature] | Cannabinoid receptor 1 [gi:1345697] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Displacement of [3H]CP-55940 from CB1 receptor in mouse brain | | AID | 409760 | | BioAssay type | Literature | | Target | Cannabinoid receptor 1 [gi:1345697] | | PubMed | 18752948 | | Data Table |  |
|
| 8 | [SID103590572] | Active | IC50 | 0.04 | Inhibition of FAAH-mediated [3H]anadamide hydrolysis in mouse brain [AID409759, Type: Literature] | Fatty-acid amide hydrolase 1 [gi:6225311] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.04 [uM] | | BioAssay | Inhibition of FAAH-mediated [3H]anadamide hydrolysis in mouse brain | | AID | 409759 | | BioAssay type | Literature | | Target | Fatty-acid amide hydrolase 1 [gi:6225311] | | PubMed | 18752948 | | Data Table |  |
|
| 9 | [SID103590572] | Active | IC50 | 0.063 | Displacement of acetylcholine from AChE in Swiss Webster mouse brain after 5 mins [AID503579, Type: Literature] | Acetylcholinesterase [gi:113038] |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.063 [uM] | | BioAssay | Displacement of acetylcholine from AChE in Swiss Webster mouse brain after 5 mins | | AID | 503579 | | BioAssay type | Literature | | Target | Acetylcholinesterase [gi:113038] | | PubMed | 18438404 | | Data Table |  |
|
| 10 | [SID103590572] | Active | IC50 | 0.063 | Displacement of acetylcholine from AChE in Swiss Webster mouse brain after 5 mins [AID503579, Type: Literature] | Acetylcholinesterase [gi:113038] |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.063 [uM] | | BioAssay | Displacement of acetylcholine from AChE in Swiss Webster mouse brain after 5 mins | | AID | 503579 | | BioAssay type | Literature | | Target | Acetylcholinesterase [gi:113038] | | PubMed | 18438404 | | Data Table |  |
|
| 11 | [SID103590572] | Active | IC50 | 0.46 | Displacement of [3H]anandamide from FAAH in Swiss Webster mouse brain after 5 mins [AID503576, Type: Literature] | Fatty-acid amide hydrolase 1 [gi:6225311] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 0.46 [uM] | | BioAssay | Displacement of [3H]anandamide from FAAH in Swiss Webster mouse brain after 5 mins | | AID | 503576 | | BioAssay type | Literature | | Target | Fatty-acid amide hydrolase 1 [gi:6225311] | | PubMed | 18438404 | | Data Table |  |
|
| 12 | [SID103590572] | Active | IC50 | 25 | Displacement of [3H]CP-55940 from mouse CB1 receptor expressed in HEK293 cells in presence of mouse brain membrane [AID409808, Type: Literature] | Cannabinoid receptor 1 [gi:1345697] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | IC50 | 25 [uM] | | BioAssay | Displacement of [3H]CP-55940 from mouse CB1 receptor expressed in HEK293 cells in presence of mouse brain membrane | | AID | 409808 | | BioAssay type | Literature | | Target | Cannabinoid receptor 1 [gi:1345697] | | PubMed | 18752948 | | Data Table |  |
|
| 13 | [SID103590572] | Active | | | Effect on CB1-dependent cannabinoid-mediated cataleptic behavior in KIAA1363-deficient Swiss Webster mouse at 100 mg/kg, ip [AID503588, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | BioAssay | Effect on CB1-dependent cannabinoid-mediated cataleptic behavior in KIAA1363-deficient Swiss Webster mouse at 100 mg/kg, ip | | AID | 503588 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 14 | [SID103590572] | Active | | | Effect on CB1-dependent cannabinoid-mediated hypomobility in Swiss Webster mouse at 2 mg/kg, ip [AID503583, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | BioAssay | Effect on CB1-dependent cannabinoid-mediated hypomobility in Swiss Webster mouse at 2 mg/kg, ip | | AID | 503583 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 15 | [SID103590572] | Active | | | Effect on CB1-dependent cannabinoid-mediated hypomobility in Swiss Webster mouse at 3 mg/kg, ip [AID503584, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | BioAssay | Effect on CB1-dependent cannabinoid-mediated hypomobility in Swiss Webster mouse at 3 mg/kg, ip | | AID | 503584 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 16 | [SID103590572] | Active | | | Effect on CB1-dependent cannabinoid-mediated hypothermia in Swiss Webster mouse at 4 mg/kg, ip [AID503586, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Active | | BioAssay | Effect on CB1-dependent cannabinoid-mediated hypothermia in Swiss Webster mouse at 4 mg/kg, ip | | AID | 503586 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 17 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as unsaturated C24:1 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503534, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as unsaturated C24:1 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503534 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 18 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as saturated C18:0 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503572, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as saturated C18:0 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503572 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 19 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as anandamide level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503400, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as anandamide level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503400 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 20 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as 2-arachidonylglycerol level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503401, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as 2-arachidonylglycerol level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503401 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 21 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as aracidonic acid level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503402, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as aracidonic acid level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503402 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 22 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as N-palmitoyl-ethanolamine level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503403, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as N-palmitoyl-ethanolamine level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503403 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 23 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as unsaturated N-oleoyl-ethanolamine level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503404, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as unsaturated N-oleoyl-ethanolamine level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503404 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 24 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as saturated C20:0 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503406, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as saturated C20:0 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503406 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 25 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as unsaturated C20:4 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503407, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as unsaturated C20:4 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503407 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 26 | [SID103590572] | Unspecified | | | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as saturated C22:0 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs [AID503408, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Disruption of endocannabinoid metabolism in Swiss Webster mouse brain assessed as saturated C22:0 fatty acid level per gram of tissue at 4 mg/kg, ip after 4 hrs | | AID | 503408 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 27 | [SID26757094] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID103590572] | Unspecified | | | Inhibition of 2-arachidonylglycerol hydrolysis in Swiss Webster mouse brain at 4 mg/kg, ip after 4 hrs [AID503577, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Inhibition of 2-arachidonylglycerol hydrolysis in Swiss Webster mouse brain at 4 mg/kg, ip after 4 hrs | | AID | 503577 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 29 | [SID103590572] | Unspecified | | | Inhibition of anandamide hydrolysis in Swiss Webster mouse brain at 4 mg/kg, ip after 4 hrs [AID503578, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Unspecified | | BioAssay | Inhibition of anandamide hydrolysis in Swiss Webster mouse brain at 4 mg/kg, ip after 4 hrs | | AID | 503578 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 30 | [SID26757094] | Inactive | Potency | | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway [AID651777, Type: confirmatory] | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway | | AID | 651777 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] | | PubMed | | | Data Table |  |
|
| 31 | [SID26757094] | Inactive | Potency | | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway [AID651777, Type: confirmatory] | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway | | AID | 651777 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] | | PubMed | | | Data Table |  |
|
| 32 | [SID26757094] | Inactive | Potency | | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway [AID651777, Type: confirmatory] | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway | | AID | 651777 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] | | PubMed | | | Data Table |  |
|
| 33 | [SID26757094] | Inactive | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_1, Type: other] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID26757094] | Inactive | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_2, Type: other] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID26757094] | Inactive | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_3, Type: other] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID26757094] | Inactive | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_4, Type: other] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID26757094] | Inactive | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_5, Type: other] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID26757094] | Inactive | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_6, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID26757094] | Inactive | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_7, Type: other] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID26757094] | Inactive | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_8, Type: other] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID103590572] | Inactive | | | Effect on CB1-dependent cannabinoid-mediated hypomobility in Swiss Webster mouse at 3 mg/kg, ip in presence of 10 mg/kg, ip CB1 receptor antagonist AM251 [AID503580, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Inactive | | BioAssay | Effect on CB1-dependent cannabinoid-mediated hypomobility in Swiss Webster mouse at 3 mg/kg, ip in presence of 10 mg/kg, ip CB1 receptor antagonist AM251 | | AID | 503580 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 42 | [SID103590572] | Inactive | | | Effect on CB1-dependent cannabinoid-mediated hypomobility in Swiss Webster mouse at 2 mg/kg, ip in presence of 10 mg/kg, ip CB1 receptor antagonist AM251 [AID503582, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Inactive | | BioAssay | Effect on CB1-dependent cannabinoid-mediated hypomobility in Swiss Webster mouse at 2 mg/kg, ip in presence of 10 mg/kg, ip CB1 receptor antagonist AM251 | | AID | 503582 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 43 | [SID103590572] | Inactive | | | Effect on CB1-dependent cannabinoid-mediated hypothermia in Swiss Webster mouse at 4 mg/kg, ip in presence of 10 mg/kg, ip CB1 receptor antagonist AM251 [AID503587, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103590572 | | CID | 21804 | | Outcome | Inactive | | BioAssay | Effect on CB1-dependent cannabinoid-mediated hypothermia in Swiss Webster mouse at 4 mg/kg, ip in presence of 10 mg/kg, ip CB1 receptor antagonist AM251 | | AID | 503587 | | BioAssay type | Literature | | Target | | | PubMed | 18438404 | | Data Table |  |
|
| 44 | [SID26757094] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 45 | [SID26757094] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 46 | [SID26757094] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 47 | [SID26757094] | Inactive | Potency | | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 48 | [SID26757094] | Inactive | Potency | | qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway [AID651749, Type: confirmatory] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway | | AID | 651749 | | BioAssay type | confirmatory | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|
| 49 | [SID26757094] | Inactive | Potency | | qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway [AID651749, Type: confirmatory] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway | | AID | 651749 | | BioAssay type | confirmatory | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|
| 50 | [SID26757094] | Inactive | Potency | | qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway [AID651749, Type: confirmatory] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26757094 | | CID | 21804 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway | | AID | 651749 | | BioAssay type | confirmatory | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|